Request Your Free Infographic Now:

"Tumor Mutational Burden Quantification Using Small- and Moderate-Sized Targeted Anchored Multiplex PCR Panels and Next-Generation Sequencing"

Tumor mutational burden (TMB) is rapidly gaining acceptance in oncology research as a key biomarker and indicator of tumor response to immune checkpoint inhibitors. Whole-exome sequencing (WES) of tumor-normal pairs is the reference standard for the calculation of TMB; however, given the cost and other workflow implications of WES, TMB is frequently derived from targeted next-generation sequencing panels.

This scientific poster from IDT describes the measurement of TMB using VariantPlex Pan Solid Tumor and VariantPlex Complete Solid Tumor panels utilizing anchored multiplex PCR chemistry for error correction and bias mitigation.

For Research Use Only. Not for use in diagnostic procedures.

Offered Free by: IDT
See All Resources from: IDT